It is starting to sound like you are now trying to convince yourself this is a bad play...
Everyone here is (or should be) aware of the risks when you invest in an otc stock. If they don't then I have no sympathy for them if and when they lose it all.
Now concerning a few of your specific points... Please show us where you found this "large toxic debt", you can't because it isn't there.
Lawsuits. They are a part of any and every business. It is that simple.
Somewhat suspect management? Haha good one, management is highly qualified. The track record is there. All you have to do is read over it. You will find much, much worse here in to the otc markets.
"Potentially and likely serious issues that were hidden via or due to the Terry Johnson debacle". That is PURE SPECULATION on your part. You have absolutely no evidence that TALK knowingly hid "potentially and likely serious issues".
Increasing debt. We just learned yesterday that they will be reducing debt by $720,000.00 a year. Enough said there.
You said, and I quote "true, perhaps the odds are a bit better than with most OTC issuers..." you just freely admitted that this is a better play than "most" others. We will be sure to quote you on that in the future.